Determine Announces 3rd Quarter Fiscal Year 2017 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
111
Determine Announces 3rd Quarter Fiscal Year 2017 Financial Results, Exceeding Revenue and Earnings Expectations

CARMEL, IN--(Marketwired - Feb 9, 2017) - Determine , Inc. ( NASDAQ : DTRM ), a leading global provider of SaaS enterprise Source to Pay and Enterprise Contract Lifecycle Management solutions, including cloud-based strategic sourcing, supplier management, contract management and procure-to-pay solutions, announced financial results for its third fiscal quarter ended December 31, 2016.

Q3 FY2017 GAAP Financial Highlights:

  • GAAP revenue was $6.9 million in Q3 FY2017, compared to $6.6 million in Q2 FY2017, representing a 4.1% increase quarter-over-quarter, and compared to $7.1 million in Q3 FY2016 GAAP revenue, representing a 3.5% decrease year-over-year.
  • GAAP gross profit percentage increased to 48.8% in Q3 FY2017, compared to 47.7% in Q2 FY2017, representing a quarter-over-quarter increase of 1.1 percentage points, and compared to 51.9% in Q3 FY2016, representing a 3.1 percentage points decrease year-over-year.
  • Deferred revenues increased 11.1% to $10.0 million in Q3 FY2017 from $9.0 million in Q3 FY2016.
  • GAAP net loss was $2.2 million or ($0.18) per share in Q3 FY2017, compared to $3.2 million or ($0.28) per share in Q2 FY2017, representing a $0.10 improvement per share quarter-over-quarter; in Q3 FY2016 the GAAP net loss was $2.8 million or ($0.25) per share.

                                                                          (in thousands, except per share amounts)

 
GAAP Financial Measures   Q3     Q2     Q3     Change     Change     Nine Months  
  FY 2017     FY 2017     FY 2016     Q/Q     Y/Y     FY 2017'     FY 2016'     Change Y/Y  
Revenue - total   $ 6,852     $ 6,584     $ 7,100       4.1 %     (3.5 %)   $ 19,928     $ 20,080       (0.8 %)
Revenue - recurring   $ 5,054     $ 5,145     $ 5,354       (1.8 %)     (5.6 %)   $ 15,267     $ 15,862       (3.8 %)
Revenue - non-recurring   $ 1,798     $ 1,439     $ 1,746       24.9 %     3.0 %   $ 4,661     $ 4,218       10.5 %
Gross profit - total   $ 3,341     $ 3,138     $ 3,682       6.5 %     (9.3 %)   $ 9,865     $ 10,494       (6.0 %)
Gross profit - recurring   $ 3,277     $ 3,442     $ 3,538       (4.8 %)     (7.4 %)   $ 10,182     $ 10,859       (6.2 %)
Gross profit/ (loss) - non-recurring   $ 64     $ (304 )   $ 144       121.0 %     (55.6 %)   $ (317 )   $ (365 )     13.2 %
Gross margin - total     48.8 %     47.7 %     51.9 %     1.1 pts       (3.1 pts )     49.5 %     52.3 %     (2.8 pts )
Gross margin - recurring     64.8 %     66.9 %     66.1 %     (2.1 pts )     (1.3 pts )     66.7 %     68.5 %     (1.8 pts )
Gross margin - non recurring     3.5 %     (21.1 %)     8.2 %     24.6 pts       (4.7 pts )     (6.8 %)     (8.7 %)     1.9 pts  
Net loss   $ (2,193 )   $ (3,207 )   $ (2,845 )     31.6 %     22.9 %   $ (7,743 )   $ (10,212 )     24.2 %
EPS   $ (0.18 )   $ (0.28 )   $ (0.25 )   $ 0.10     $ 0.07     $ (0.67 )   $ (0.90 )   $ 0.23  
                                                                 

Q3 FY2017 Non-GAAP Financial Highlights:

  • Non-GAAP revenue was $6.9 million in Q3 FY2017, compared to $6.6 million in Q2 FY2017, representing a 4.1% quarter-over-quarter increase, and compared to $7.2 million in Q3 FY2016, representing a 4.7% decrease year-over-year.
  • Non-GAAP gross profit percentage was 54.4% in Q3 FY2017, compared to 52.5% in Q2 FY2017, representing a 1.9 percentage point increase, and compared to 57.5% in Q3 FY2016, representing a 3.1 percentage point decrease.
  • Non-GAAP net loss was $1.0 million or ($0.08) per share in Q3 FY2017, compared to $2.0 million or ($0.17) per share in Q2 FY2017, representing an improvement of $0.09 per share quarter-over-quarter, compared to $1.5 million or ($0.13) per share in Q3 FY2016, representing a $0.05 improvement per share year-over-year.
  • Billings decreased 3.3% to $7.5 million in Q3 FY2017 from $7.8 million in Q3 FY2016. Billings, a non-GAAP measure, are defined as revenue plus the change in deferred revenues.
  • Non-GAAP EBITDA was ($0.2) million in Q3 FY2017, and compared to ($1.4) million in Q3 FY2016, representing an improvement of $1.2 million year-over-year.

(in thousands, except per share amounts)                                                                          

 
Non-GAAP Financial Measures   Q3     Q2     Q3     Change     Change     Nine Months  
  FY 2017     FY 2017     FY 2016     Q/Q     Y/Y     FY 2017'     FY 2016'     Change Y/Y  
Revenue - total   $ 6,852     $ 6,584     $ 7,187       4.1 %     (4.7 %)   $ 19,936     $ 20,308       (1.8 %)
Revenue - recurring   $ 5,054     $ 5,145     $ 5,400       (1.8 %)     (6.4 %)   $ 15,275     $ 16,021       (4.7 %)
Revenue - non-recurring   $ 1,798     $ 1,439     $ 1,787       24.9 %     0.6 %   $ 4,661     $ 4,287       8.7 %
Gross profit - total   $ 3,726     $ 3,460     $ 4,135       7.7 %     (9.9 %)   $ 10,896     $ 11,677       (6.7 %)
Gross profit - recurring   $ 3,591     $ 3,710     $ 3,859       (3.2 %)     (7.0 %)   $ 11,037     $ 11,736       (6.0 %)
Gross profit/( loss) - non-recurring   $ 135     $ (250 )   $ 276       154.0 %     (51.1 %)   $ (141 )   $ (59 )     (139.0 %)
Gross margin - total     54.4 %     52.5 %     57.5 %     1.9 pts       (3.1 pts )     54.7 %     57.5 %     (2.8 pts )
Gross margin - recurring     71.0 %     72.1 %     71.5 %     (1.1 pts )     (0.5 pts )     72.3 %     73.3 %     (1.0 pts )
Gross margin - non recurring     7.5 %     (17.4 %)     15.5 %     24.9 pts       (8.0 pts )     (3.0 %)     (1.4 %)     (1.6 pts )
Net loss   $ (1,010 )   $ (1,959 )   $ (1,503 )     48.4 %     32.8 %   $ (4,253 )   $ (4,585 )     7.2 %
EPS   $ (0.08 )   $ (0.17 )   $ (0.13 )   $ 0.09     $ 0.05     $ (0.37 )   $ (0.45 )   $ 0.08  
Billings   $ 7,545     $ 5,770     $ 7,800       30.8 %     (3.3 %)   $ 19,595     $ 20,667       (5.2 %)
                                                                 

"This quarter we are very pleased by our return to the million dollar range for new Annualized Bookings, with quarter-over-quarter new sales growing at a rate in excess of 30%. Driving the sales performance was our disruptive, new Determine Cloud Platform offering, with over 90% of our new customers opting for the platform for their Source-to-Pay or Enterprise Contract Lifecycle Management needs," said Patrick Stakenas, President and CEO of Determine. "Over the coming months, we look forward to continuing to focus on several key executional tasks including advancing the Determine Cloud Platform's capabilities -- to provide our customers with 'Platformance', continuing to optimize organizational efficiencies, and building upon our robust lead pipeline to deliver incremental and accelerated sales in the coming quarters."

Q3 FY2017 Business Highlights:

  • Annualized Bookings: The sales team delivered approximately $983,000 in Annualized Bookings for the quarter, with more than 90% of new customers selecting the new Determine Cloud Platform for their Source-to-Pay or Contract Lifecycle Management needs.
  • Determine Cloud Platform Empowers Companies in Source-to-Pay and Enterprise Contract Lifecycle Management: During Q3 FY2017, Determine introduced a range of additional benefits that empower customers to deliver results now, and as they grow. These include the following improvements to the Determine Cloud Platform : improved supplier certification and compliance through triggered automation based on answers provided during registration and supplier monitoring, side-by-side comparison of contract requests and attachments for enhanced version control and user authorization, time tracking for services procurement that requires calendar management, PO matching, and automatic receipt/invoice generation. In addition, the Determine Cloud Platform mobile application is now available on Google Play and the Apple Store.
  • Business Analyst Recognition across the Determine Cloud Platform: In Q3 FY2017, Determine achieved a number of important recognitions from leading industry analyst organizations:
  • New Leadership: In October 2016, Determine appointed Steve Potts as Chief Revenue Officer. Steve brings over thirty years of sales management, sales performance management, and sales training experience in the enterprise software and SaaS sectors. He most recently served as Chief Sales and Marketing Officer at AXIOM Sales Force Development, a leading cloud-based sales training and productivity improvement supplier.
  • New Customer Expansions: During Q3 FY2017, Determine engaged numerous new customer accounts in the US and Europe across its Determine Cloud Platform Source-to-Pay and Enterprise Contract Lifecycle Management solutions. Determine added new customers to its portfolio including companies in key verticals such as energy, financial, healthcare products, consumer goods, manufacturing, and retail.
  • Thought Leadership: In Q3 FY2017, Determine continued to provide meaningful educational resources to inform our customers and prospects on the ever-changing Source-to-Pay and Enterprise Contract Lifecycle Management landscape:

Conference Call and Webcast: Thursday, February 9, 2017 at 5:00 PM (Eastern Time) Participant Conference Call Numbers: Toll-Free: 1-877- 407-0789 Toll/International: 1-201- 689-8562 Participant Webcast Link: http://public.viavid.com/index.php?id=122692 Replay Dial-in Information: Toll-Free: 1-844- 512-2921 Toll/International: 1-412- 317-6671 From: 02/09/17 @ 8:00 pm Eastern Time To: 02/16/17 @ 11:59 pm Eastern Time Replay Pin Number: 13653707 Related: http://investor.determine.com

Supporting Resources Determine blog Determine on LinkedIn Determine on Twitter Determine Resources

Non-GAAP Financial Measures

To supplement our financial results presented in accordance with Generally Accepted Accounting Principles (GAAP), this press release and the accompanying tables contain certain non-GAAP financial measures, including non-GAAP revenue, non-GAAP gross profit, non-GAAP net income and non-GAAP earnings per share, which we believe are helpful in understanding our past financial performance and future results. For reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the section of the accompanying tables titled, "GAAP to Non-GAAP Reconciliations". Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The difference between GAAP and non-GAAP revenue is due to the impact of revaluing the deferred revenue balances acquired from primarily b-pack, Inc. as required by GAAP purchase accounting.

The difference between GAAP and non-GAAP gross profit is the difference in GAAP versus non-GAAP revenues as well as the elimination of the amortization of acquisition related intangibles, stock based compensation and severance expense from the costs of revenue. Non-GAAP net loss excludes the non-GAAP gross profit items as well as acquisition related costs.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand and manage our business and forecast future periods; as such, we believe it is useful for investors to understand the effects of these items on our total operations. Further, please note that our non-GAAP revenue is intended to reflect the full amount of revenues that would have been otherwise recorded by the acquired entities of Iasta.com, Inc. and b-pack, Inc. while our non-GAAP gross profit also excludes the amortization of intangibles that occurred due to the acquisition of the entities of Iasta.com, Inc. and b-pack, Inc.

Annualized Bookings are an operating measure not derived from the company's revenues or any other amounts presented in accordance with GAAP in the company's statement of income, balance sheet, statement of cash flows or other equivalent statements.

"Annualized Bookings" means the annualized recurring contracted revenue from a new customer or a cross-sell or upsell to an existing customer.

Forward-looking Statements

Certain statements in this release and elsewhere by Determine are forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements regarding business outlook, assessment of market conditions, anticipated financial and operating results, strategies, product and channel development, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward-looking statements include, but are not limited to fluctuations in demand for Determine's products and services, risks of losing key personnel or customers, protection of the company's intellectual property and government policies and regulations, including, but not limited to those affecting the company's industry. Determine undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Additional risk factors concerning the company can be found in the company's most recent Form 10-K as filed by the company with the Securities and Exchange Commission.

About Determine, Inc.

Determine, Inc. ( NASDAQ : DTRM ) is a leading global provider of SaaS Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) solutions. Our visionary technologies allow our customers to effectively manage the full scope of Source-to-Pay and Enterprise Contract Lifecycle Management using our Determine Cloud Platform. Our Source to Pay SaaS suite includes strategic sourcing, supplier management, contract management and procure-to-pay applications.

The Determine Cloud Platform gives procurement, finance and legal professionals the ability to deliver profound insights through analysis of their supplier relationships and contractual requirements. Our customers leverage the Determine Cloud Platform to discover previously unseen supplier and spend data; make more informed and smarter business decisions; drive new revenue; control costs; improve workflow efficiencies; and mitigate risk.

Our customers benefit from the Determine Cloud Platform's robust suite of integrated applications. Whether they start with a full-suite implementation or choose to implement just one application and build over time, each application allows for the automatic sharing of data in place on the Determine Cloud Platform.

For more information, please visit: www.determine.com .

   
   
   
Determine, Inc.  
Condensed Consolidated Statements of Operations  
(In thousands, except per share amounts)  
(Unaudited)  
               
      Three Months Ended     Nine Months Ended  
      December 31     December 31  
      2016     2015     2016     2015  
                                   
Revenues:                              
  Recurring revenues $ 5,054       5,354     $ 15,267     $ 15,862  
  Non-recurring revenues   1,798       1,746       4,661       4,218  
  Total revenues   6,852       7,100       19,928       20,080  
                                   
Cost of revenues:                              
  Cost of recurring revenues   1,777       1,816       5,085       5,003  
  Cost of non-recurring revenues   1,734       1,602       4,978       4,583  
  Total cost of revenues   3,511       3,418       10,063       9,586  
                                   
Gross profit:                              
  Recurring gross profit   3,277       3,538       10,182       10,859  
  Non-recurring profit (loss)   64       144       (317 )     (365 )
  Total gross profit   3,341       3,682       9,865       10,494  
                                   
Operating expenses:                              
  Research and development   1,049       1,230       3,052       2,851  
  Sales and marketing   2,273       3,310       7,843       10,313  
  General and administrative   1,761       2,072       5,432       6,211  
  Impairment of software devlopment costs   -       -       947          
    Total operating expenses   5,083       6,612       16,327       19,375  
                                   
Loss from operations   (1,742 )     (2,930 )     (6,462 )     (8,881 )
                                   
Interest and other (expense), net   (462 )     (149 )     (1,388 )     (549 )
Net loss before income tax   (2,204 )     (3,079 )     (7,850 )     (9,430 )
                                   
Benefit from income taxes   35       233       143       213  
Net loss   (2,169 )     (2,846 )     (7,707 )     (9,217 )
                                   
Net income (loss) attributed to non-controlling interest   (24 )     1       (36 )     5  
Net loss attributable to Determine, Inc.   (2,193 )     (2,845 )     (7,743 )     (9,212 )
                                   
Redeemable preferred stock accretion   -       -       -       1,000  
Net loss attributable to common stockholders $ (2,193 )   $ (2,845 )   $ (7,743 )   $ (10,212 )
                                   
Basic and diluted net loss per share $ (0.18 )   $ (0.25 )   $ (0.67 )   $ (0.90 )
                                   
                           
                           
Determine, Inc.  
GAAP to Non-GAAP Reconciliations  
(In thousands)  
(Unaudited)  
                                   
Reconciliation of total revenue:                              
  U.S. GAAP as reported $ 6,852     $ 7,100     $ 19,928     $ 20,080  
  Adjustments:                              
  Deferred revenue adjustment   -       87       8       228  
Non-GAAP revenue $ 6,852     $ 7,187     $ 19,936     $ 20,308  
                                   
Reconciliation of gross profit:                              
  U.S. GAAP as reported $ 3,341     $ 3,682     $ 9,865     $ 10,494  
  Adjustments:                              
  Deferred revenue adjustment   -       87       8       228  
  Amortizaton of acquision   250       250       758       630  
  Stock based compensation   111       92       240       218  
  Severance   24       24       25       107  
Non-GAAP gross profit $ 3,726     $ 4,135     $ 10,896     $ 11,677  
                                   
Reconciliation to non-GAAP net loss:                              
Net loss $ (2,193 )   $ (2,845 )   $ (7,743 )   $ (9,212 )
Stock-based compensation expense   630       658       1,867       1,871  
Deferred revenue adjustment   -       87       8       228  
Acquisition related costs   -       138       -       912  
Amortization on intangibles   526       542       1,594       1,373  
Benefit for income taxes   -       (213 )     (13 )     (213 )
Severance costs   27       130       34       456  
Non-GAAP net loss $ (1,010 )   $ (1,503 )   $ (4,253 )   $ (4,585 )
                                   
Non-GAAP basic and diluted net loss per share $ (0.08 )   $ (0.13 )   $ (0.37 )   $ (0.45 )
                                   
Weighted average shares outstanding for basic                              
and diluted net loss per share   11,944       11,244       11,466       10,212  
                                   
                         
                         
Determine, Inc.  
Condensed Consolidated Statements of Comprehensive Loss  
(In thousands)  
(Unaudited)  
   
    Three Months Ended     Nine Months Ended  
    December 31     December 31  
    2016     2015     2016     2015  
                                 
Net loss   $ (2,169 )   $ (2,846 )   $ (7,707 )   $ (9,217 )
Other comprehensive income (loss) net:                                
  Foreign currency translation adjustments     44       (11 )     31       (68 )
  Non-controlling interest     (24 )     1       (36 )     5  
Other comprehensive income (loss)     20       (10 )     (5 )     (63 )
Comprehensive loss   $ (2,149 )   $ (2,856 )   $ (7,712 )   $ (9,280 )
                                 
                                 
         
Determine, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
         
         
         
    December 31,   March 31,
    2016   2016
    (Unaudited)   (Audited)
ASSETS            
Current assets            
  Cash and cash equivalents   $ 9,387   $ 9,418
  Accounts receivable, net     6,759     7,031
  Restricted cash     34     34
  Prepaid expenses and other current assets     1,408     1,551
    Total current assets     17,588     18,034
             
Property and equipment, net     94     136
Capitalized software, net     2,131     1,699
Goodwill     14,346     14,490
Other intangibles, net     6,346     8,011
Other assets     1,492     1,843
    Total assets   $ 41,997   $ 44,213
             
             
LIABILITIES AND EQUITY            
Current liabilities            
  Credit facility   $ 10,861   $ 9,000
  Accounts payable     2,435     1,973
  Accrued payroll and related liabilities     1,802     1,655
  Other accrued liabilities     2,020     2,396
  Deferred revenue     10,028     10,299
  Income tax payable     78     14
  COFACE loan     222     407
  Accrued restructuring     -     403
    Total current liabilities     27,446     26,147
  Long-term deferred revenue     5     67
  Convertible note, net of debt discount     7,374     5,420
  Other long-term liabilities     1,055     1,382
  Deferred tax liability non current     81     290
    Total liabilities     35,961     33,306
             
Total Determine, Inc. stockholders' equity controlling interest     5,887     10,794
Non-controlling interest     149     113
Total equity     6,036     10,907
    Total liabilities and equity   $ 41,997   $ 44,213
             
             
             
Determine, Inc.  
Condensed Consolidated Statements of Cash Flows  
(In thousands)  
(Unudited)  
             
             
    Nine Months Ended  
    December 31,     December 31,  
    2016     2015  
                 
Operating activities                
Net loss   $ (7,707 )   $ (9,217 )
Adjustments to reconcile net loss to net cash used in                
operating activities:                
  Depreciation and amortization     2,478       1,868  
  Loss on disposition of property and equipment     -       14  
  Stock-based compensation expense     1,867       1,870  
  Deferred tax liability     (209 )     93  
Changes in assets and liabilities:                
  Accounts receivable, net     272       149  
  Prepaid expenses and other current assets     143       300  
  Other assets     435       (380 )
  Accounts payable     462       113  
  Accrued payroll and related liabilities     147       278  
  Accrued restructuring costs     (403 )     -  
  Other accrued liabilities and other long-term liabilities     (356 )     (13 )
  Deferred revenue     (333 )     (281 )
Net cash used in operating activities     (3,204 )     (5,206 )
                 
Investing activities                
  Purchase of property and equipment     (39 )     (6 )
  Capitalized software     (1,267 )     (1,077 )
  Purchase of business, net of cash     -       (826 )
  Minority shareholder payment     -       (133 )
Net cash used in investing activities     (1,306 )     (2,042 )
                 
Financing activities                
  Proceeds from sale of common stock, preferred stock and warrants, net of issuance costs     -       310  
  Employee taxes paid in exchange for restricted stock awards forefeited     78       263  
  Issuance of common stock under employee stock plan     80       87  
  Credit facility borrowing     3,000       885  
  Credit facility payment     (1,139 )     (347 )
  Repayment of loan     (185 )     (25 )
  Conversion of preferred stock to common stock     -       (17 )
  Issuance of debt, net of costs     2,429       2,743  
Net cash provided by financing activities     4,263       3,899  
                 
  Effect of exchange rate changes on cash     216       11  
                 
Net decrease in cash and cash equivalents     (31 )     (3,338 )
Cash and cash equivalents at beginning of the period     9,418       13,178  
Cash and cash equivalents at end of the period   $ 9,387     $ 9,840  
                 
                         
                         
Determine, Inc.  
Billings Reconciliation  
(In thousands)  
(Unaudited)  
                         
                         
    Three Months Ended     Nine Months Ended  
    December 31,     December 31,     December 31,     December 31,  
    2016     2015     2016     2015  
                                 
Total revenues   $ 6,852     $ 7,100     $ 19,928     $ 20,080  
Deferred revenue:                                
End of period     10,033       9,019       10,033       9,019  
Beginning of period     9,340       8,319       10,366       8,432  
Change in deferred revenue     693       700       (333 )     587  
Total billings (total revenues plus the change in deferred revenue)   $ 7,545     $ 7,800     $ 19,595     $ 20,667  
                                 
                                 
                                 
Determine, Inc.  
Non-GAAP EBITDA Reconciliation  
(In thousands)  
(unaudited)  
                         
    Three Months Ended     Nine Months Ended  
    December 31     December 31  
    2016     2015     2016     2015  
Reconciliation to non-GAAP EBITDA net loss:                                
Non-GAAP net loss   $ (1,010 )   $ (1,503 )   $ (4,253 )   $ (4,585 )
Interest     461       131       1,299       372  
Depreciation     348       161       916       498  
Income Taxes and Minority Shareholder     (11 )     (233 )     (107 )     (217 )
Non-GAAP EBITDA net loss   $ (212 )   $ (1,444 )   $ (2,145 )   $ (3,932 )
                                 

 

Contact Media Relations Rose Lee Determine, Inc. +1.877.806.1932 +1.650.532.1590 pr@determine.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 214

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 0

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Runway Growth Acquires SWK Holdings in Major Merger Deal

Updated Category News Views 292

Runway Growth Announces Acquisition of SWK Holdings Runway Growth Finance Corp. (NASDAQ: RWAY) has made a significant move by announcing its acquisition of SWK Holdings Corporation (NASDAQ: SWKH). This strategic deal, valued at around $220 million, reflects Runway's ambition to enhance its investment portfolio. Details of the Acquisition Deal The acquisition will be...

Continue Reading
Generative AI Market for Software and Coding Set for Growth

Updated Category News Views 149

Overview of the Generative AI Market The Generative AI in Software and Coding market is on a promising trajectory, with projections indicating a remarkable increase from USD 31.6 million by 2024 to USD 243.7 million by 2033, a CAGR of 25.5%. This growth reflects the rise of AI technologies capable of automating code generation and software development, streamlining...

Continue Reading
Explore NebulaGraph Cloud: Affordable Beta Access Awaits

Updated Category News Views 77

NebulaGraph Cloud Beta Preview on AWS Global We’re launching the beta preview of NebulaGraph Cloud on AWS Global, and you can try it for up to $1 for a full month. Starting now through the end of November, you can explore a highly scalable, high?performance graph database without a big upfront commitment. Spin it up, kick the tires, and see how it fits your workload....

Continue Reading
Exploring Gold's Surge: Implications for GoldHaven Resources

Updated Category News Views 198

Gold Prices Rise Amid Economic Turmoil Gold prices have experienced a remarkable rise, surging over 25% since the start of the year and stabilizing near the $4,000 per ounce mark. This increase is driven by a wave of investors looking for safe-haven assets amidst persistent inflation and economic uncertainty. Central banks have noticeably been boosting their gold...

Continue Reading
Illinois Tool Works Adjusts Earnings Outlook Amid Observer Changes

Updated Category News Views 237

Illinois Tool Works Inc. Announcements Following Q3 Results Illinois Tool Works Inc. (NYSE: ITW) recently released its third-quarter results for fiscal 2025, showcasing a mix of performance metrics that caught the interest of analysts and investors alike. The company reported a revenue increase of 2.3% year-over-year, amounting to $4.06 billion. However, this result fell...

Continue Reading